// App-Quantinova.ai

7.2 1727 : Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real‐world setting

Researchers

Presenter

  • Clark A

Principal Investigators

  • Zolkipli Q

  • Powell E

  • Ewan P

Medical Centers

  • Cambridge University Hospitals, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Glomeruloid microvascular proliferation

  • Immunoglobulin E

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved